Objectives: Intrathecal opioids offer very calm also effectual technique of extending postoperatively analgesia owing to their achievement on spinal opioid receptors. Nalbuphine remains the diverse opioid agonist - antagonist that got improved side effect outline as compared to morphine. This remains very effortlessly accessible in Bangladesh deprived of the requirement for narcotics license. Methodology: This existing research was conducted at Lahore General Hospital Lahore from September 2018 to March 2019. Overall seventy respondents experiencing numerous inferior stomachs also inferior limb operations remained randomized into 3 sets also established moreover 0.9 mg or 0.7 mg intrathecal nalbuphine by 2.3 ml of 0.6% hyperbaric bupivacaine. The period of postoperatively analgesia, hemodynamic constancy also occurrence of opposing properties remained distinguished. Results: The average period of postoperatively analgesia in 0.9 mg also 0.7 mg set remained 248 ± 13 also 238 ± 12 minutes correspondingly (p = 0.008). The occurrence of bradycardia remained additional in 0.7 mg set but then again did not influence statistical implication. The incapability of developed quantity to attain lengthier analgesia may remain owing to the ceiling result also anti-analgesic activities of nalbuphine. Conclusion: The quantity of 0.9mg of nalbuphine by way of an intrathecal adjuvant appears to stay optimal for offering lengthy pole-operatively painlessness by negligible side effects. Keywords: Nalbuphine; Postoperatively aching; Anesthesia, SA.